Key Takeaways
- Margins jumped despite a revenue dip: Gross margins improved sharply QoQ, driven by product mix and strong US operations, even as topline fell on seasonal softness and low capacity utilization.
- Capacity utilization collapsed to 66%: Newly added 7,000 MT at Jhagadia and Dahej sits largely empty, pulling utilization down from 94% in March 2024; management expects these lines to fill by FY26.
- The balance sheet is being rapidly deleveraged: Debt is expected to reach near-zero by year-end, with short-term loans being paid down and liquid assets offsetting remaining working capital.
- API is a regulatory story, not a revenue story yet: Three CEPs filed with EDQM, nine targeted this year, but regulated-market revenue will be miniscule in FY25 because approvals take roughly nine months.
- What to watch next quarter: Whether capacity utilization begins to climb from 66%, the CCS environmental clearance arrives within four weeks, and any capsule coating technology announcement materializes.
Capacity & Volume Recovery
- The utilization hole: Overall capacity utilization fell to 66% in Q1 from 94% at March 2024 because expanded capacities of 7,000 MT added at Jhagadia and Dahej are not yet occupied.
- Filling the lines: Management expects these expanded capacities to be fully occupied by FY26, with the first impact of increased capacity visible in the coming quarter (Q2 FY25).
- MCC pricing strategy: Pricing is moderate this quarter with no significant growth as the company concentrates on volumes to fill capacities; pricing is expected to remain stable, not increase much but will not come down, though management also stated pricing will increase going forward.
- Seasonal Q1 pattern: The QoQ revenue decline is consistent with a 6-7 year historical pattern where Q1 sales are always lower than the preceding Q4.
- Order book structure: Repeat orders constitute 80% of volumes and value, with new business at 20%; new orders can include the same customer using MCC for a different finished product.
Margin & Return Profile
- Margin improvement mechanics: Margins increased drastically QoQ despite lower revenues due to product mix and strong US operations performance.
- Bottom-line sustainability: Management stated bottom-line margins will be maintained for the time being, with sustainability confirmed, and will increase going forward but not immediately.
- ROE dipped on investment: ROE has declined due to investments into the system and will improve once expanded capacity reaches peak utilization; management gave only a vague answer on specific FY25/FY26 ROE figures, saying "this year also more or less small change would be there, going forward it will improve."
- O&M margin ceiling: Margins of 20-23% in O&M are reasonable because asset owners understand the process economics and will not allow margins of 35-40%.
Amit Raj Sinha: "Until the product is a dangerous process or until there are very high technical capabilities essential, the margins, I do not see them going so much beyond. Because the OEM or the asset owners also purview of our picture of what does that whole process entail. So, they are not going to let us go with a margin of 35%, 40%. I do not see that happening anytime."
Operations & Maintenance (O&M) Business
- Business model: Sigachi operates chemical process plants for large players (e.g., Grasim's stable bleaching powder plant) using the client's assets and utilities, delivering cost savings and yield improvements.
- Revenue model: Revenue is a mix of production; the more the client produces and sells, the more revenue Sigachi earns.
- Contract durations: Most contracts, including Grasim, Adani Solar, and Adani Enterprise, are for five-year periods.
- Adani Solar added: Adani Solar Power at Mundra was added to the O&M client roster this quarter, though management declined to explain the production process or USP behind winning the contract, calling it outside the earnings call purview.
- Middle East ambition: The Middle East is described as a complete O&M market where owners do not run their own plants; Sigachi is building competence in desalination plants to qualify and participate in tenders there.
- Sigachi Arabia: A collaboration with Saudi National Projects Investment Limited was established, but management declined to give any revenue number for the current year, calling it "very premature" as they are still setting up bank accounts and placing people.
Amit Raj Sinha: "Middle East is a complete O&M market. That means everything in the Middle East runs on operation and management. The owners do not run their plants anytime."
API & Regulatory Pathway
- Current state: API is currently sold only domestically; the regulatory market focus will take approximately nine months for approvals from EDQM.
- CEP filings: Three CEP filings for API products have been made with EDQM (European Union), with a target to file a total of nine CEPs in the current financial year.
- Revenue timeline: Revenue from regulated markets for APIs in the current financial year will be miniscule and insignificant; approvals are expected to commence in another nine months, with the sales cycle for regulated markets starting after that.
- Capacity expansion: Plan to expand API capacity from 100 KL to 250 KL with CAPEX of approximately ₹60 crores.
New Initiatives & Capex
- CCS facility at Dahej: A Cross Carmellose Sodium and complex excipient facility is being set up 1 km from the original unit, with initial capacity of 1,800 MTPA (scalable to 3,600 MTPA) and CAPEX of approximately ₹90 crores.
- Environmental clearance: Gujarat Pollution Control Board EC Committee review was completed four days before the call, all queries cleared, and the EC clearance document is expected in the next four weeks.
- Capsule coating technology: The company is building excitement on social media for a launch described as "revolutionary technology"; a press release to the stock exchange will come on the appropriate day, which is "reasonably close."
- No new CAPEX: No new CAPEX is planned in the next two to three years beyond what has already been announced.
- Sigachi Arabia CAPEX: The company will commit to CAPEX in Saudi Arabia only after three years if business there moves ahead positively.
Amit Raj Sinha: "No, it is not too far, it is close by. That's why the excitement. Otherwise, the social media, the memory is just about 24 hours to 48 hours, it will be down."
Balance Sheet & Working Capital
- Debt reduction trajectory: Debt is expected to reach almost zero by the end of this year; the company is paying off short-term loans during the year, with only working capital remaining, and liquid assets (margin money, FDs) offsetting that.
- Warrant proceeds clarification: An analyst pointed out a discrepancy between the warrant proceeds utilization table showing ₹0 spent at Dahej/Jhagadia/Hyderabad as of June 30 and management's claim that 95% was spent. Management explained that spending was done from internal accruals and bank debt first, and warrant proceeds will repay those loans, so the expenditure was technically incurred but not yet from warrant funds.
- Collection period: The company has concentrated on reducing the debtor collection period, targeting at least a 30-day reduction overall this year, with further slow reductions thereafter.
- Inventory build: Raw material prices are going up, so the company is strategically increasing raw material inventory; some countries have currency issues causing delays but no threat of non-payment.
Revenue Mix & Growth Ambition
- Long-term revenue mix target: APIs at 35-40%, O&M at 20-25%, balance from excipients (MCC plus CCS), with food and nutrition at less than 5%.
- MCC share declining by design: MCC absolute value is going up, but its revenue share is declining as the company diversifies with steady revenue streams from other activities becoming core.
- Growth commitment: The company has always claimed 25% CAGR growth and is working to continue maintaining or bettering this; minimum growth expected is 25%, and it can go much further using available capacity.
- O&M growth multiplier: Expertise gained with Adani is expected to multiply manifold with other industries in India and possibly the Middle East.
Amit Raj Sinha: "I believe, that at least 35% to 40% of our revenue should be coming in from the API, operations and management should add in to around 20%, 25%, and the balance should be from the excipients, not just MCC because we will also have Cross Carmellose sodium."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Capacity utilization | Expanded capacities at Jhagadia and Dahej fully occupied | By FY26 |
| CCS environmental clearance | EC clearance document received | Within next four weeks |
| API CEP filings | Total of nine CEPs filed for APIs | Current financial year |
| API regulated-market approvals | First CEP approvals from EDQM received | Approximately nine months |
| API regulated-market revenue | Miniscule/insignificant revenue from regulated markets | Current financial year |
| API capacity expansion | Expand from 100 KL to 250 KL, CAPEX ~₹60 crores | Not specified |
| CCS facility | Initial capacity 1,800 MTPA, CAPEX ~₹90 crores | Not specified |
| Debt reduction | Debt at almost zero level | By end of this year |
| Debtor collection period | At least 30 days reduction | This year |
| Revenue growth | Minimum 25% CAGR maintained or bettered | Ongoing |
| Bottom-line margins | Maintained for time being, increase going forward but not immediately | Ongoing |
| Sigachi Arabia CAPEX | CAPEX committed in Saudi | After three years, conditional on business moving positively |
| New CAPEX | No new CAPEX planned | Next two to three years |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Operating income | ₹96 cr, +13% YoY |
| EBITDA | ₹21 cr, +28.05% YoY, margin of 21.94% |
| Net profit | ₹12.8 cr, +17.43% YoY, PAT margin of 13.38% |
| MCC revenue | ₹71.83 cr, +2.79% YoY from ₹69.88 cr |
| O&M revenue | ₹10.10 cr, +18.54% YoY from ₹8.52 cr |
| API segment revenue | ₹8.99 cr |
| MCC capacity utilization | 66% overall (Dahej 56%, Jhagadia 53%, Hyderabad 86%), down from 94% as of March 2024 due to expanded capacities yet to be occupied |
| API capacity utilization | ~70% |
| MCC combined capacity | 21,000 MTPA across Dahej, Jhagadia and Hyderabad |
| CCS facility planned CAPEX | ~₹90 cr, initial capacity 1,800 MTPA scalable to 3,600 MTPA |
| API planned expansion CAPEX | ~₹60 cr to expand from 100 KL to 250 KL |
| MCC export share | Two-thirds of MCC revenue, domestic one-third |
| Repeat order share | 80% of volumes and value, new business development 20% |
| Order book | Healthy six months in place |
| Debt expectation | Almost zero by end of FY25 |